Transparency in the EU's Vaccines Strategy 18-09-2020


ESIP joins the Fair Pricing Coalition calling for transparent investment on COVID-19 vaccines

The COVID-19 crisis has put strains on healthcare system in Europe and across the world. In the attempt to overcome the crisis, the EU engaged in a number of measures and initiatives aimed at countering disruptions in the European health, economic and social systems. Amongst others, the COVID-19 European vaccine strategy, based on Advance Purchase Agreements (APAs), has been used for the join procurement of vaccines for COVID-19.

A stronger Health Union but no Social Europe? 16-09-2020


State of the European Union speech 2020

On 16 September, the European Commission President Ursula von der Leyen gave her first State of the Union speech at an undeniably crucial moment for the EU. Starting her speech with a recognition of the dedication of healthcare staff and essential workers during the COVID crisis, she then highlighted the EU level cooperation in the field of health.


The future of EU Pharma beyond COVID-19 15-09-2020


ESIP responds to the Public Consultation on the EU Pharmaceutical Strategy

Ahead of the release of the Pharmaceutical Strategy for Europe, the European Social Insurance Platform (ESIP) submitted its contribution to the related Public Consultation and welcomed the Commission’s initiative to ensure equal access to safe, quality and affordable medicines, while promoting the sustainability of healthcare systems.

ESIP is recruiting a motivated secretary 07-08-2020


Job offer for a part-time secretary

The European Social Insurance Platform (ESIP) aisbl, which represents over 50 national statutory social insurance organisations in 17 EU Member States, the UK and Switzerland, dedicated to shaping the future of social security in Europe, is looking for an experienced, highly motivated and results-driven secretary to support our international office in Brussels.